Press Releases Starpharma Holdings Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:45 2024-04-26 am EDT			5-day change	1st Jan Change
0.135 ^AUD	0.00%		+3.85%	-20.59%

Apr. 08	Starpharma, Medicxi Co-Found Petalion Therapeutics; Shares Surge 16%	MT
Mar. 18	Starpharma Holdings Limited(ASX:SPL) dropped from S&P/ASX Emerging Companies Index	CI

Starpharma with Proactive at the ASX Small and Mid-Cap Conference	23-03-22	AQ
Starpharma : Quarterly Activities Report & Appendix 4C	22-07-28	PU
Starpharma : Quarterly Cashflow and Activities Report	22-04-28	PU
Starpharma : Application for quotation of securities - SPL	22-03-17	PU
Starpharma : Interim Report and Half-Year Financial Results	22-02-20	PU
Starpharma : Application for quotation of securities - SPL	22-02-01	PU
Starpharma - Quarterly Cashflow and Activities Report	22-01-31	AQ
Starpharma : Quarterly Cashflow and Activities Report	22-01-27	PU
Starpharma receives $7.7M R&D tax incentive refund	22-01-21	AQ
Starpharma - VIRALEZE antiviral nasal spray registered in Saudi Arabia	21-12-15	AQ
Starpharma : Notification regarding unquoted securities - SPL	21-12-02	PU
Starpharma : AGM Chairman address and CEO presentation	21-11-29	PU
Starpharma to present at Bell Potter Healthcare Conference	21-11-08	PU
Starpharma : VIRALEZE™ now launched by LloydsPharmacy in the UK	21-03-29	PU
Starpharma : VIRALEZE to be launched with Lloyds Pharmacy in the UK	21-03-25	AQ
Starpharma : VIRALEZE™ to be launched with LloydsPharmacy in the UK	21-03-24	PU
Starpharma : DEP HER2-lutetium outperforms in human breast cancer model	21-03-17	AQ
Starpharma : DEP® HER2-lutetium outperforms in human breast cancer model	21-03-15	PU
Starpharma : SPL7013 active against other pandemic coronaviruses	21-03-04	AQ
Starpharma : VIRALEZE antiviral nasal spray registered in Europe	21-02-23	AQ

No results for this search